NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Galvanize Therapeutics

Galvanize Therapeutics

Private
Redwood City, CaliforniaHealthcare & Life Scienceshttps://galvanizetx.com/

Last Round

Series C

Sep 3, 2025

Total Funding Raised

$218M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Galvanize Therapeutics is a medical technology company that develops energy-based devices utilizing high-voltage electrical pulses to enhance biological processes for improved patient care.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotech Equipment

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

pulsed electric fieldPEFsurgical ablationnon-thermal ablationsoft tissue oncologymedical devicetumor ablationinterventional oncologyelectrosurgical deviceablation probeminimally invasive surgerymedtechsurgical hardwarebiopsy integration

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Galvanize Therapeutics Comparables

Compare Galvanize Therapeutics with similar companies based on industry and business-model similarity.

Galvanize Therapeutics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap

View Full Comparables Set

Access detailed peer comparisons, similarity scores, and market data.

Galvanize Therapeutics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series CSep 3, 2025
Series BSep 15, 2022
Series AMar 16, 2021

Key People

Founding team and executive leadership

Jonathan Waldstreicher

Founder CEO

Founding Team

Steven Anheier

Chief Financial Officer

Executive Team

Kevin Taylor

Chief Operating Officer

Executive Team

William Krimsky

Chief Medical Officer

Executive Team

Galvanize Therapeutics Investors

Notable investors and investment history

Galvanize Therapeutics investors
InvestorRounds
Janus Henderson GroupSeries C
Perceptive AdvisorsSeries C
Ally Bridge GroupSeries C
Gilmartin CapitalSeries B, Series C
LongaevaSeries C
Fidelity Management & Research CompanySeries C, Series B
Apple Tree PartnersSeries B, Series C, Series A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Oct 1, 2025

    Senior PM hire signals market development for Aliya PEF platform.

  • Sep 3, 2025

    $100M round raised.

Galvanize Therapeutics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Galvanize Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Galvanize Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersRedwood City, California
Employee Range171
Year Founded2015
Last FundingSep 3, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.